Handling anxiety and panic during benzodiazepine withdrawal
Reducing or stopping a benzodiazepine can cause anxiety, panic, palpitations, sweating, tremor and insomnia. These reactions may resemble the original anxiety returning, but they can also reflect physical adaptation to regular use, creating a risky cycle of increasing doses.
This guide explains how to manage anxiety and panic attacks during benzodiazepine withdrawal without abrupt discontinuation or unprescribed substitutes. Safe care usually combines a clinician-supervised taper, grounding techniques and mental-health support matched to withdrawal severity and other health conditions.
Recognising withdrawal-related panic
Symptoms may begin within a day or two after reducing a short-acting medicine, while longer-acting medicines can take several days. Anxiety often fluctuates in waves, and panic attacks can occur without immediate danger. This general withdrawal information provides orientation, but personal advice should come from a prescriber.
Seek urgent help for a seizure, hallucinations, severe confusion, repeated vomiting, suicidal thoughts or loss of awareness. Call 000 or attend an emergency department. These signs need medical assessment because benzodiazepine withdrawal can rarely cause delirium or other serious complications.
Building a supervised taper
Ask the prescriber, GP or another qualified clinician to create an individual taper. The plan may alter dose frequency, use short-term symptom support and include reviews. If a medicine has already been stopped and symptoms are severe, disclose that clearly; emergency or inpatient care may be safer than restarting a schedule independently.
Under the TGA’s Poisons Standard, alprazolam is a Schedule 8 medicine and many other benzodiazepines are Schedule 4; state prescription rules also apply. These controls do not make unsupervised stopping appropriate. Ask one community pharmacy to coordinate repeats and counsel you through the taper.
Grounding during a panic surge
During a panic surge, breathe comfortably in for four counts and out for six; do not force deep breaths or hold your breath. Name five things you see, four you touch, three you hear, two you smell and one you taste. These practical anxiety coping ideas can add grounding prompts between appointments.
If symptoms begin while driving, pull over safely before using the technique. Rural road safety guidance is a reminder that long rural routes can delay care. Tell someone your location, and seek urgent assessment if panic is severe or comes with chest pain, fainting or breathing difficulty.
Protecting sleep and avoiding substitutes
Insomnia may persist after daytime anxiety improves. Keep a consistent wake time, seek morning daylight and activity, reduce late caffeine and dim screens before bed; avoid alcohol and online sedatives. Ask the prescriber to review the taper and any underlying sleep problem rather than taking extra doses.
Gabapentin or pregabalin are sometimes prescribed for pain or sleep, but they are not risk-free substitutes. Gabapentin dependence information can inform a discussion with a clinician about misuse, sedation and withdrawal. Do not add, borrow or swap medicines without a prescription, since combined sedatives can slow breathing.
Using Australian support services
Most Australians can start with a GP, who can assess withdrawal, manage a taper and refer to psychiatry, addiction or mental-health services. A Mental Health Care Plan may support Medicare-subsidised psychology. The Head to Health phone, 1800 595 212, connects callers to local mental-health support, while the National Alcohol and Other Drug Hotline is 1800 250 250.
Access varies by location. Sydney, Melbourne and Brisbane have public mental-health services and hospital emergency departments, while regional and rural patients may depend more on telehealth, a local GP and pharmacy delivery. Healthdirect on 1800 022 222 can direct people to after-hours care. Because benzodiazepines are prescription medicines, check the PBS subsidy for each drug.
Checking the credibility of information
Reliable guidance comes from clinicians, pharmacists, Healthdirect, the Royal Australian and New Zealand College of Psychiatrists and the Australian Prescriber, rather than commercial pages promising a guaranteed detox. Australian addiction services and public alcohol and drug teams can assess withdrawal and explain referrals.
International material can illustrate different systems but cannot verify local care. An overview of affordable detox options shows how insurance shapes access in Florida, yet US costs and rules do not apply here. Use it only for comparison and contact an Australian prescriber or health service for a suitable programme.
Comparing care pathways
Care intensity should match withdrawal severity, previous attempts and coexisting conditions. A stable taper may be managed in primary care, while recurrent panic or complicated prescribing may require specialist support.
| Care pathway | What it provides | Key access point and caution |
|---|---|---|
| GP-led taper | Assessment, scripts and monitoring | Public referral is unnecessary; dose changes should remain clinician-led |
| Psychiatrist or addiction specialist | Complex withdrawal and high-risk prescribing | A referral or private fees may apply |
| Mental-health team | Panic treatment and brief crisis support | Call Head to Health on 1800 595 212; not every service runs a dedicated benzodiazepine programme |
| Community pharmacy | Medication review and repeat coordination | Ask one pharmacy to coordinate the plan; it cannot manage every high-risk withdrawal alone |
Urgent physical symptoms should never wait for a routine appointment. Call 000 or attend the nearest emergency department in a crisis; for non-emergency guidance, Healthdirect is available on 1800 022 222.